FDA 483 - Evive Biopharmaceutical (Beijing), Ltd. - June 07, 2023
FDA 483 for Evive Biopharmaceutical (Beijing), Ltd. on June 07, 2023. Product: drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for Evive Biopharmaceutical (Beijing), Ltd. on June 07, 2023. Product: drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
June 7, 2023
Product Type
drugs
ID: 87b1727c-cc54-4864-bae5-00782ae476e8
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox